Report Detail

Request for Sample of this report

Other Global Radiopharmaceuticals in Nuclear Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3344102
    • |
  • 22 April, 2019
    • |
  • Global
    • |
  • 138 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Scope of the Report:
The worldwide market for Radiopharmaceuticals in Nuclear Medicine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Radiopharmaceuticals in Nuclear Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes

Market Segment by Applications, can be divided into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales, revenue and global market share of Radiopharmaceuticals in Nuclear Medicine in 2017 and 2018.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Radiopharmaceuticals in Nuclear Medicine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Diagnostic Radiopharmaceuticals
      • 1.2.2 Therapy Radiopharmaceuticals
      • 1.2.3 Enriched Stable Isotopes
    • 1.3 Market Analysis by Applications
      • 1.3.1 Diagnostic Application
      • 1.3.2 Therapeutic Application
      • 1.3.3 Research
      • 1.3.4 Pharmaceutical
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bracco Imaging S.P.A.
      • 2.1.1 Business Overview
      • 2.1.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Cambridge Isotope Laboratories, Inc.
      • 2.2.1 Business Overview
      • 2.2.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Cardinal Health, Inc.
      • 2.3.1 Business Overview
      • 2.3.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Covidien, Plc
      • 2.4.1 Business Overview
      • 2.4.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Eczacibasi-Monrol
      • 2.5.1 Business Overview
      • 2.5.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Fujifilm Holdings Corporation
      • 2.6.1 Business Overview
      • 2.6.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 GE Healthcare (Subsidiary Of General Electric Company)
      • 2.7.1 Business Overview
      • 2.7.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 IBA Group
      • 2.8.1 Business Overview
      • 2.8.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Isotec, Inc. (Sigma-Aldrich)
      • 2.9.1 Business Overview
      • 2.9.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Lantheus Medical Imaging, Inc.
      • 2.10.1 Business Overview
      • 2.10.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Nordion, Inc.
      • 2.11.1 Business Overview
      • 2.11.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Ntp Radioisotopes (Pty), Ltd.
      • 2.12.1 Business Overview
      • 2.12.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
      • 2.13.1 Business Overview
      • 2.13.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Taiyo Nippon Sanso Corporation
      • 2.14.1 Business Overview
      • 2.14.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Urenco Limited
      • 2.15.1 Business Overview
      • 2.15.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Rotem Industries, Ltd., Inc.
      • 2.16.1 Business Overview
      • 2.16.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Australian Nuclear Association And Technology Organization (ANSTO)
      • 2.17.1 Business Overview
      • 2.17.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Board of Radiation And Isotope Technology (BRIT)
      • 2.18.1 Business Overview
      • 2.18.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Institute of Atomic Energy Polatom Radioisotope Centre
      • 2.19.1 Business Overview
      • 2.19.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Institute of Isotopes Co., Ltd.
      • 2.20.1 Business Overview
      • 2.20.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Institute Of Radioelement (IRE)
      • 2.21.1 Business Overview
      • 2.2.2 Radiopharmaceuticals in Nuclear Medicine Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Radiopharmaceuticals in Nuclear Medicine Market Analysis by Regions

    • 4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.5 South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    5 North America Radiopharmaceuticals in Nuclear Medicine by Country

    • 5.1 North America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    6 Europe Radiopharmaceuticals in Nuclear Medicine by Country

    • 6.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.3 UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.4 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine by Country

    • 7.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.5 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    8 South America Radiopharmaceuticals in Nuclear Medicine by Country

    • 8.1 South America Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine by Countries

    • 9.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2014-2019)

    10 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Type

    • 10.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2014-2019)
    • 10.2 Diagnostic Radiopharmaceuticals Sales Growth and Price
      • 10.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth (2014-2019)
      • 10.2.2 Global Diagnostic Radiopharmaceuticals Price (2014-2019)
    • 10.3 Therapy Radiopharmaceuticals Sales Growth and Price
      • 10.3.1 Global Therapy Radiopharmaceuticals Sales Growth (2014-2019)
      • 10.3.2 Global Therapy Radiopharmaceuticals Price (2014-2019)
    • 10.4 Enriched Stable Isotopes Sales Growth and Price
      • 10.4.1 Global Enriched Stable Isotopes Sales Growth (2014-2019)
      • 10.4.2 Global Enriched Stable Isotopes Price (2014-2019)

    11 Global Radiopharmaceuticals in Nuclear Medicine Market Segment by Application

    • 11.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2014-2019)
    • 11.2 Diagnostic Application Sales Growth (2014-2019)
    • 11.3 Therapeutic Application Sales Growth (2014-2019)
    • 11.4 Research Sales Growth (2014-2019)
    • 11.5 Pharmaceutical Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)

    • 12.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.4 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast (2019-2024)
    • 12.3 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Type (2019-2024)
    • 12.4 Radiopharmaceuticals in Nuclear Medicine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Radiopharmaceuticals in Nuclear Medicine. Industry analysis & Market Report on Radiopharmaceuticals in Nuclear Medicine is a syndicated market report, published as Global Radiopharmaceuticals in Nuclear Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Radiopharmaceuticals in Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,686.56
      		4,029.84
      		5,373.12
      		3,201.60
      		4,802.40
      		6,403.20
      		530,108.40
      		795,162.60
      		1,060,216.80
      		292,772.40
      		439,158.60
      		585,544.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo